Sickness behaviors, such as fatigue, mood alterations, and cognitive dysfunction, which result from changes in central neurotransmission, are prevalent in systemic inflammatory diseases and greatly impact patient quality of life. Although, microglia (resident cerebral immune cells) and cytokines (e.g., TNF␣) are associated with changes in central neurotransmission, the link between peripheral organ inflammation, circulating cytokine signaling, and microglial activation remains poorly understood. Here we demonstrate, using cerebral intravital microscopy, that in response to liver inflammation, there is increased monocyte specific rolling and adhesion along cerebral endothelial cells (CECs). Peripheral TNF␣-TNFR1 signaling and the adhesion molecule P-selectin are central mediators of these monocyte-CEC adhesive interactions which were found to be closely associated with microglial activation, decreased central neural excitability and sickness behavior development. Similar monocyte-CEC adhesive interactions were also observed in another mouse model of peripheral organ inflammation (i.e., 2,4-dinitrobenzene sulfonic acid-induced colitis). Our observations provide a clear link between peripheral organ inflammation and cerebral changes that impact behavior, which can potentially allow for novel therapeutic interventions in patients with systemic inflammatory diseases.
Introduction
Sickness behaviors, such as fatigue, mood disorders, and cognitive dysfunction are prevalent in patients with inflammatory diseases (e.g., inflammatory bowel disease, rheumatoid arthritis, inflammatory liver disease) and greatly impact quality of life (Lorton et al., 2008; Graff et al., 2011) . Neural and humoral pathways have been postulated to mediate periphery-to-brain communication in systemic inflammation (Capuron and Miller, 2011) . Previously, using a murine model of hepatic inflammation, we identified an immune mediated periphery-to-brain communication pathway whereby circulating monocytes enter brain parenchyma; an event linked to expression of liver inflammation-associated sickness behaviors ). However, cerebral monocyte recruitment did not occur until Ͼ5 d after induction of liver inflammation ); yet sickness behaviors and activation of microglia are evident well before monocyte infiltration is detectable (Nguyen et al., 2012) . This suggests that monocyte entry into the brain is not obligatory for initiation of central changes accompanying peripheral inflammation.
Microglial activation has been linked with behavioral alterations and with regulation of central neural excitability (Henry et al., 2008; . In mice with liver inflammation, we have previously shown that at a time when cerebral monocyte recruitment is not evident, circulating monocytes express TNF␣. At this time point, blocking peripheral TNF␣ signaling markedly reduced microglial activation ). However, the cellular mechanisms that link peripheral TNF␣ signaling to microglial activation during peripheral organ inflammation have not previously been examined. Elucidation of this pathway could have broad implications for management of detrimental behavior alterations in patients with systemic inflammatory diseases.
TNF␣ is a potent activator of endothelial cells and can promote rolling/adhesion of leukocytes along cerebral endothelial cells (CECs) (Carvalho-Tavares et al., 2000) . Importantly, both anti-TNF␣ and anti-leukocyte adhesion therapies (specifically anti-␣ 4 integrin therapy) are associated with improvements in quality of life, Rudick et al., 2007) . Furthermore, in a mouse model of pilocarpine-induced seizures, rolling/adhesion of neutrophils along CECs was found to alter central neural excitability (Fabene et al., 2008) . We hypothesized that during hepatic inflammation, circulating monocytes may interact with, and subsequently activate CECs. A signaling molecule(s) could in turn be released from stimulated CECs to activate cells within the brain, which could contribute to altered central neurotransmission. In our present study we examined sickness behaviors, and central neural excitability, as indicators of changes in neurotransmission within the brain. We find that at a time when cerebral monocyte recruitment is not evident, mice with hepatic inflammation exhibit sickness behaviors, as well as reduced central neural excitability in vitro and increases in seizure threshold (a robust and reproducible neural excitability readout) in vivo. We show that hepatic inflammation causes increased monocyte-endothelium adhesive interactions, specifically in the cerebral vasculature. P-selectin driven monocyte-CEC adhesive interactions subsequently lead to microglial activation, changes in central neural excitability, and sickness behaviors. Importantly, we also demonstrate that leukocyte-CEC adhesive interactions occur in a model of inflammatory bowel disease; findings suggesting this periphery-to-brain communication pathway may be generalizable to a number of different diseases.
Materials and Methods
Mice. Mice (all on C57BL/6 genetic background; male 6 -8-weeks-old) were purchased from The Jackson Laboratory and maintained in a pathogen free facility. Lysozyme (LysM) mice were obtained from Dr. Paul Kubes (University of Calgary, Calgary, Alberta, Canada). All procedures conformed to guidelines established by Canadian Council on Animal Care.
Model of hepatic inflammation. We used a well characterized model of relatively acute hepatic inflammation due to bile duct ligation (BDL; sham-ligated mice served as controls) (Kerfoot et al., 2006; Nguyen et al., 2012) . In general, this model likely reflects periphery-to-brain signaling pathways, which occur early in the clinical course of acute liver or gastrointestinal inflammatory diseases (e.g., acute hepatitis or gastroenteritis). This model is associated with elevated circulating cytokines (e.g.: TNF␣, IL-6) and development of sickness behaviors (Burak et al., 2002; Nguyen et al., 2008 Nguyen et al., , 2012 . All experiments were performed 5 d post-BDL, a time point when the liver is significantly inflamed and cerebral monocyte infiltration is not evident . Biochemical evidence of liver injury was demonstrated by an increase in serum alanine aminotransferase (enzyme released by damaged hepatocytes) and total bilirubin levels. None of the interventions described herein altered the magnitude of liver inflammation in BDL mice (Table 1) .
Biochemical analysis. Alanine aminotransferase and bilirubin levels were measured in a commercial lab (Calgary Laboratory Services).
Induction of colitis. Colitis was induced in anesthetized mice via the intrarectal delivery of 3 mg of 2, 4-dinitrobenzene sulfonic acid (DNBS) in 100 l of 1:1 PBS/ethanol via a 3 cm catheter as described previously (Hunter et al., 2010) . Control mice received vehicle. Cerebral intravital microscopy was performed 3 d post-DNBS when colitis is maximal.
Examination of hippocampal excitability in vitro. We measured alterations in hippocampal excitability in vitro in brain slices from sham and BDL mice using methods previously described by our group . We chose the hippocampal region because of its well-studied structure, role in seizure generation, and established methods of neural excitability evaluation. Epileptiform events can be induced in hippocampal slices with a variety of chemical convulsants, and data from these types of experiments demonstrate the intrinsic excitability of the tissue and bypass any possibility of altered convulsive drug accessibility to the brain in a disease model.
Mice were anesthetized with isoflurane, decapitated, and brains immediately removed and kept in 0 -4°C high magnesium high sucrose slicing solution (87 mM NaCl, 2.5 mM KCl, 25 mM NaHCO 3 , 1.25 mM NaH 2 PO 4, 25 mM D-glucose, 7 mM MgCl 2 , 0.48 mM CaCl 2 , and 142 mM sucrose) that was bubbled with 5% CO 2 /95% O 2 . Horizontal hippocampal slices of 400 m were cut and maintained for 1 h in artificial CSF (aCSF; 126 mM NaCl, 2.5 mM KCl, 1.2 mM NaH 2 PO 4 , 1.2 mM MgCl 2 , 2.4 mM CaCl 2 , 18 mM NaHCO 3 , 11 mM D-glucose, and 1.5 mM kynurenic acid) at 32°C and continuously bubbled with 5% CO 2 /95% O 2 . Slices were then transferred to another chamber containing only aCSF without kynurenic acid and bubbled with 5% CO 2 /95% O 2 at room temperature for at least 2 h before recording. For recording, slices were transferred to a submerged recording chamber and perfused with aCSF at 31 Ϯ 1°C. Signals were acquired using an Axopatch 200A amplifier (Molecular Devices; low-pass filter, 5 kHz; high-pass filter, 1 Hz; acquisition frequency, 10 kHz; gain, 500ϫ). An aCSF-filled glass micropipette recording electrode (4-6 m⍀) was used for recording. Spontaneous interictal activity was induced by bath perfusion with aCSF containing 75 M 4-aminopyridine for 30 min and was recorded from CA1 stratum pyramidale. The average frequency of the interictal events in the last 10 min of 4-aminopyridine application was counted and analyzed.
Central neural excitability measurements. In freely moving mice, 1% pentylenetetrazole solution (Sigma-Aldrich) was infused at 0.58 ml/min via a lateral tail vein cannula. The infusion was halted as soon as the mouse developed clonic seizures (four limb clonus and loss of balance) and amount of pentylenetetrazole/body weight (mg/kg) required to induce seizures was calculated as an index of brain neural excitability (Mandhane et al., 2007; .
Administration of minocycline, anti-TNF␣ serum, and anti-P-selectin antibody. To inhibit microglial activation, we administered minocycline on days 2 and 4 post-BDL (45 mg/kg, i.p.; Wu et al., 2002; Yenari et al., 2006) dissolved in intralipid (20%; Baxter) to reduce injection pain. Although minocycline has pleitropic effects, it has been extensively used in murine models to examine the effects of inhibiting microglial activation (Yenari et al., 2006; Biscaro et al., 2012) . For peripheral TNF␣ inhibition studies, mice were injected with normal rabbit serum (NRS) or anti-TNF␣ serum (0.5 ml i.p., kindly provided by Dr C. Hogaboam, University of Michigan) on days 2 and 4 post-BDL. For anti-P-selectin inhibition studies, mice received rat IgG 1 antibody or anti-P-selectin antibody (RB40 -34, 1 mg/kg; BD Biosciences) on days 2 and 4 post-BDL (Kerfoot et al., 2006; .
Sickness behavior assessment. Social investigative behavior and duration of immobility as measures of sickness behavior were assessed as previously described (D'Mello et al., 2009). Leukocyte isolation and flow cytometry analysis. Isolation of leukocytes from peripheral blood and cerebral cortices was done using previously described protocols (Kerfoot et al., 2006; . Previously, we examined cerebral microglial activation in terms of MCP-1/ CCL2 expression because we were interested in examining the role of microglial activation in mediating recruitment of CCR2 ϩ monocytes into the brain in BDL mice ). In our current study, we used an additional method to examine microglial activation whereby expression of CD11b coupled with the differential expression of CD45 antigen, as determined by flow cytometry, was used to distinguish between resting/activated microglia and infiltrating monocytes (Sedgwick et al., 1991; Getts et al., 2008) . Based on these criteria, resting and activated microglia are defined as CD45 low CD11b ϩ and CD45 intermediate CD11b ϩ cells, respectively. For depletion of circulating neutrophils, mice were treated with anti-Gr-1 antibody (4 mg/kg, i.p., eBioscience) for 20 h; controls received rat IgG 2 b antibody (Kim et al., 2009; Stirling et al., 2009 ). Neutrophils were identified by surface expression of GFP and PElabeled Ly6G (eBioscience).
Isolation of CECs. CECs were isolated from brain using previously described methods (Tontsch and Bauer, 1989) . Brains were removed and homogenized in ice-cold sucrose buffer. Homogenates were then centrifuged at 1000 ϫ g (10 min, 4°C). The supernatant was discarded and the pellet resuspended in cold sucrose buffer, followed by centrifugation at 1000 ϫ g. This was repeated one more time. The microvessels in the resulting pellet were then incubated in 0.075% collagenase (SigmaAldrich) for 15 min at 37°C. Cells were then centrifuged at 200 ϫ g (10 min, 4°C) and further purified by incubation with CD31 microbeads (1 g/10 6 cells; Miltenyi Biotec) followed by positive selection sorting using an AutoMacs (Miltenyi Biotec). To determine TNFR expression, cells were labeled simultaneously with a FITC-labeled anti-CD31 antibody (BD Biosciences) and PE-labeled anti-TNFR1 (AbD Serotec) or anti-TNFR2 (BD Biosciences) antibodies and analyzed by flow cytometry.
Immunohistochemistry for iba-1, iNOS, and CD34. For detection of ionized calcium binding adapter molecule (Iba)-1 ϩ microglia, paraffinembedded brain sections (6 m) were deparaffinized and then underwent heat-induced antigen retrieval in citrate buffer for 45 min. Following PBS wash, 10% normal goat serum (VWR) was applied for 1 h (25°C). Primary anti-mouse Iba-1 antibody (1:1000, Wako) was applied overnight (25°C). Following two PBS washes, biotinylated anti-rabbit IgG (Vecto) antibody was applied for 1 h (25°C). Bound antibody was detected using an ABC kit (Vector) followed by application of diaminobenzidine (Vector) as a substrate for color development. Resting microglia were identified as "ramified" microglia with long processes, whereas primed/activated microglia were identified as microglial cells that were more ameboid, with retracted and shorter processes (Ahmed et al., 2007) .
For detection of inducible nitric oxide synthase (iNOS) and CD34 (endothelial cell marker), the same deparaffinization and antigen retrieval steps as described above were followed. Primary rabbit antimouse iNOS (1:250, Santa Cruz Biotechnology) and rat anti-mouse CD34 (1:50, Abcam) antibodies were then applied for 20 h at 4°C. This was followed by application of goat anti-rabbit AlexaFlour 555 (1:300) and goat anti-rat AlexaFlour 488 (1:400, 1 h, 25°C; Invitrogen) antibodies. To quench autofluorescence, brain sections were incubated with Sudan black (3%, 10 min; Sigma-Aldrich) and then mounted with Prolong Gold (Invitrogen).
Cerebral intravital microscopy. Intravital microscopy of cerebral vasculature was conducted as previously described (Carvalho-Tavares et al., 2000; Kerfoot et al., 2006) . Briefly, under ketamine (100 mg/kg)/xylazine (10 mg/kg) anesthetic, a craniotomy was performed and the dura mater removed to expose the underlying pial vasculature. The mouse was maintained at 37°C and the tail vein was cannulated for administration of dyes and antibodies.
Rhodamine-6G dye (0.3 mg/kg, Sigma-Aldrich) was used to label all circulating leukocytes (Carvalho-Tavares et al., 2000; Kerfoot et al., 2006) ; CECs were labeled with a FITC/APC-labeled anti-CD31 antibody (2 g/mouse, i.v., eBioscience; Stirling et al., 2009; Lee et al., 2010). For identification of rolling/adherent monocytes, mice were injected with PE-labeled F4/80 antibody (1 g/mouse, i.v., eBioscience; Lee et al., 2010) . Five vessels of 30 -70-m-diameter were recorded for 1 min and data averaged. Rolling leukocytes were defined as cells that moved at a velocity less than that of an erythrocyte, past a given point within a 100 m vessel segment. Adherent leukocytes were defined as cells that remained stationary for 30 s or longer within a 100 m vessel segment (Kerfoot et al., 2006) .
Leukocyte-endothelial interactions were imaged using Quorum WaveFX spinning disk confocal microscope driven by Volocity 6.1 acquisition software (PerkinElmer). Labeled cells were imaged using 491, 561, or 635 nm laser excitation and visualized with the appropriate longpass filters using a 10ϫ/0.33 NA air objective. A 512 ϫ 512 pixel backthinned EMCCD camera (Model C9100-13; Hamamatsu) was used for fluorescence detection.
Intravital microscopy of cremaster vasculature. Intravital microscopy of cremaster vasculature was performed as previously described (Liu et al., 2005) . Transmitted bright field microscopy was used to visualize the microcirculation in the cremaster muscle on a custom microscope using a 20ϫ/0.4 NA air objective lens (LD Plan-Neofluar, Zeiss). Images were recorded with a Sony DXC-190 CCD color video camera, and real-time images were recorded using a DVD recorder.
Statistical analysis. Data were analyzed using GraphPad Instat and SPSS software. For comparison between two means, Student's unpaired t test was used. For multiple-comparisons, one-way ANOVA followed by Tukey's post hoc tests or Kruskal-Wallis test followed by Dunnett's post hoc tests were used. p Ͻ 0.05 was considered significant.
Results

Microglia are activated and associated with decreased central neural excitability and sickness behaviors
Changes in behavior, cognition, and mood which commonly complicate peripheral inflammatory diseases, are by definition due to altered central neurotransmission. The hippocampus has important roles in regulation of mood and behavior (Hu et al., 2012) . Therefore, we performed in vitro recordings in freshly prepared hippocampal slices and demonstrated decreased neural excitability in BDL mice (Fig. 1A) . To examine whether central neural excitability was altered in BDL mice in vivo, we determined the threshold for clonic seizures induced by timed intravenous infusion of pentylenetetrazole to enable calculation of seizure threshold (Mandhane et al., 2007; . There was a significant increase in seizure threshold in BDL mice (Fig. 1B) . In addition, we assessed social investigative behavior and duration of immobility, as measures of sickness . We found that BDL mice demonstrated significantly greater sickness behaviors (Fig. 1C) .
We next wanted to determine whether microglial activation is associated with the observed changes in seizure threshold and sickness behaviors. We found a significant increase in the number of activated microglia in BDL mice (Fig. 1D) . As we found no difference in the total number of microglial cells (i.e., resting and activated cells) isolated from sham and BDL mice, this suggests that a proportion of resting microglia are activated to increase their CD45 expression in BDL mice. In addition, activated microglia expressed higher levels of CD11b (Fig. 1E) . Furthermore, immunohistochemistry for Iba-1 ϩ microglia indicated that microglia in the hippocampal region in BDL mice predominantly exhibit a morphology typical of activated microglia (Ahmed et al., 2007) , whereas microglia in sham mice had a "resting" morphology (Fig. 1F ) .
To determine whether microglial activation contributed to the observed changes in seizure threshold and sickness behaviors, these variables were assessed in BDL mice treated with minocycline. BDL mice administered minocycline exhibited seizure thresholds similar to those in controls, as well as significant im-provements in sickness behaviors (Fig.  1 B, C) . Furthermore, minocycline treatment did not alter level of liver inflammation (Table 1) .
TNF␣-TNFR1 signaling drives microglial activation, neural excitability, and sickness behaviors There was a marked reduction in the number of activated microglia in BDL mice administered anti-TNF␣ serum systemically (Fig. 2 A, B) . As TNF␣ can mediate its effects via TNFR1 and/or TNFR2 (Cabal-Hierro and Lazo, 2012), we conducted studies in TNFR1 or TNFR2 deficient BDL mice to determine which receptor mediates TNF␣ effects upon microglial activation. The number of activated microglia was significantly reduced in TNFR1, but not TNFR2, deficient BDL mice (Fig. 2B) .
To examine whether peripheral TNF␣ signaling also contributed to alterations in neural excitability and sickness behaviors in BDL mice, we examined these variables in anti-TNF␣ treated BDL mice (as above). Increased seizure thresholds were not seen in anti-TNF␣ treated or in TNFR1 KO BDL mice, but were still present in TNFR2 KO BDL mice (Fig. 2C) . In addition, anti-TNF␣ treated BDL mice showed decreased sickness behaviors compared with controls (Fig. 2D) .
iNOS is upregulated in CECs and associated with microglial activation TNF␣ can stimulate nitric oxide production in CECs (Shafer and Murphy, 1997), which in turn can signal cells within the brain. Therefore, as a readout for nitric oxide involvement, we determined whether upregulated iNOS was linked to microglial activation. BDL mice demonstrated clear iNOS expression in CECs in the cortical region, which was not evident in sham controls (Fig. 3A) . Importantly, induction of CEC iNOS expression was strikingly attenuated in anti-TNF␣-treated and TNFR1 KO BDL mice. In addition, BDL mice deficient in iNOS had reduced numbers of activated microglia (Fig. 3B,C) .
Monocytes interact with CECs in BDL mice
As iNOS in CECs was upregulated by TNF␣, we next examined how peripheral TNF␣ activates CECs. We hypothesized that TNF␣ upregulates adhesion molecule expression on CECs, thereby promoting rolling and adhesion of leukocytes along CECs. We used intravital microscopy to examine leukocyte-endothelial interactions within the cerebral vascula- Figure 1 . Microglial activation mediates changes in neural excitability and sickness behaviors in BDL mice. A, Representative traces of 4 aminopyridine-initiated epileptiform events recorded from CA1 stratum pyramidale in hippocampal slices. Bar graph demonstrates significant decrease of epileptiform events in BDL mice; n ϭ 6/group, *p Ͻ 0.05. B, PTZ seizure thresholds (amount of PTZ in mg/kg required to induce clonic seizures) in D5 sham and BDL mice treated with saline or minocycline on days 2 and 4 postsurgery; n ϭ 6 -9/group; *p Ͻ 0.01 versus sham-saline group, #p Ͻ 0.05 versus BDL-saline group. C, Total time in seconds adult test mouse spent in social exploration or remained immobile during a 5 min observation period; n ϭ 3-5/group, *p Ͻ 0.05. D, Total number of microglia (i.e., CD11b ϩ CD45 low and CD11b ture. Cortical blood vessels were visualized through a small cranial window using a spinning disk confocal microscope as previously described (Kerfoot et al., 2006) . We observed a striking increase in rolling and adherent leukocytes along CECs in BDL mice (Fig. 4A) . To determine whether these leukocytes were a specific cell type, we conducted cerebral intravital microscopy studies in LysM mice (Faust et al., 2000) in which myeloid cells (i.e., monocytes and neutrophils) are GFP ϩ . The number of GFP ϩ cells that rolled/adhered along CECs in LysM BDL mice was similar to numbers documented in wild-type BDL mice (Fig.  4B ). To further demonstrate that only myeloid cells were interacting with CECs, we performed intravital microscopy in LysM mice administered rhodamine-6G which labels all circulating leukocytes. No GFP Ϫ rhodamine ϩ cells were observed rolling/ adherent along CECs in LysM BDL mice, indicating that only monocytes and/or neutrophils were interacting with CECs (Fig.  4C) . To determine whether GFP ϩ cells interacting with CECs were monocytes, we treated LysM BDL mice with low-dose antiGr-1 antibody to deplete circulating neutrophils (Kim et al., 2009; Stirling et al., 2009 ). Although Gr-1 is a differentiation marker expressed on neutrophils and at low levels on monocytes, low-dose anti-Gr-1 antibody has been shown to effectively deplete neutrophils without affecting circulating monocytes (Stirling et al., 2009 ). This treatment resulted in ϳ90% depletion of circulating neutrophils (Fig. 4D) ; however, we found no difference in the number of GFP ϩ cells that rolled or were adherent along CECs in anti-Gr-1 vs IgG treated BDL mice (Fig. 4E) . To confirm that cells interacting with CECs were F4/80 ϩ monocytes, LysM BDL mice were administered an anti-F4/80 antibody (Lee et al., 2010) which indicated that cells interacting with CECs were specifically monocytes (Fig. 4F ) . These data collectively demonstrate that in BDL mice, there is a specific increase in the number of monocytes interacting with CECs. We also confirmed that no monocytes infiltrated the brain of LysM BDL mice at this time point (as isolated from cerebral cortices and characterized by flow cytometry; no. of GFP ϩ , CD11b ϩ , CD45 high cells in D5 LysM sham: 1139 Ϯ 43 vs LysM BDL mice: 1240 Ϯ 57, n ϭ 6/group, p Ͼ 0.05).
To determine whether the observed monocyte rolling and adhesion was specific to the cerebral vasculature, we conducted intravital studies of the cremaster vasculature (a vascular site commonly used for studying the effects of systemic endothelial activating stimuli on leukocyte rolling/adhesion; Liu et al., 2005) in sham and BDL mice. We found no significant difference in the number of adherent leukocytes (sham: 3.2 Ϯ 0.6 and BDL: 4.8 Ϯ 0.7, n ϭ 5/group, p Ͼ 0.05) along the cremaster vascular endothelium. Furthermore, to determine whether leukocyte-CEC adhesive interactions were generalizable to another model of peripheral organ inflammation, we induced colitis in mice using DNBS (a widely used model of inflammatory bowel disease; Hunter et al., 2010) . We observed a striking increase in leukocyte-CEC adhesive interactions in mice with experimental colitis (Fig. 4G) .
TNF␣-TNFR1 signaling drives monocyte rolling and adhesion along CECs
To examine whether peripheral TNF␣ signaling drives these observed monocyte-CEC interactions, we treated BDL mice systemically with anti-TNF␣ serum (as above), and examined monocyte-CEC adhesive interactions. We found a marked reduction in the number of monocyte-CEC adhesive interactions in anti-TNF␣ treated BDL mice (Fig. 5 A, B) . To determine which receptor mediated these TNF␣ effects, we first isolated CECs from sham and BDL mice and examined TNFR expression by flow cytometry. The percentage of CECs that expressed detectable levels of TNFR1 or TNFR2 was similar in sham and BDL mice; however, the mean cell expression of TNFR1 compared with TNFR2 was Ͼ3-fold higher in CECs from sham and BDL mice (by FACs; mean fluorescence intensity of TNFR1 expression; sham: 1436 Ϯ 53 vs BDL: 1418 Ϯ 89, n ϭ 5 mice/group, p Ͼ 0.05; mean fluorescence intensity of TNFR2 expression; sham: 428 Ϯ 18 vs BDL: 390 Ϯ 23, n ϭ 5 mice/group, p Ͼ 0.05). To determine whether TNF␣ signaled via TNFR1 and/or TNFR2 to drive activation of CECs, and subsequent rolling/adhesion of monocytes, intravital microscopy was conducted in BDL mice deficient in TNFR1 or TNFR2. We found a significant decrease in rolling/adherent leukocytes along CECs in TNFR1 KO but not TNFR2 KO BDL mice (Fig. 5C-F ) .
P-selectin mediates monocyte-CEC adhesive interactions which are associated with microglial activation, decreased neural excitability, and sickness behaviors We next asked whether there was a link between monocyte-CEC adhesive interactions, microglial activation, and changes in neural excitability and sickness behaviors in BDL mice. TNF␣ is known to upregulate expression of adhesion molecules, such as P-selectin on CECs (Carvalho-Tavares et al., 2000) . Furthermore, monocytes express adhesion molecules, such as P-selectin glycoprotein ligand (PSGL)-1, which is a ligand for P-selectin (Shi and Pamer, 2011) . To determine whether P-selectin mediated the observed monocyte-CEC interactions, BDL mice were treated systemically with an anti-P-selectin antibody. Blocking of P-selectin prevented rolling and adhesion of monocytes along CECs in BDL mice (Fig. 6A) . Similar findings were also made in PSGL-1 KO BDL mice (Fig.  6B) . Furthermore, inhibition of monocyte rolling and adhesion with an anti-P-selectin antibody resulted in a significant reduction in the number of activated microglia, as well as normalization of seizure thresholds and improvement in sickness behaviors (Fig.  6C-E ).
Discussion
Our current investigations reveal a novel mechanism whereby in the setting of an inflammatory process occurring outside the brain, a TNF␣-TNFR1 and P-selectin driven rolling and adhesion specifically of monocytes occurs along CECs. Monocyte-mediated signaling events at the level of the cerebral vasculature have a key role in inducing signals into the brain, ultimately leading to activation of microglia, changes in neural excitability, and sickness behavior development. These studies may help explain why patients with peripheral inflammatory diseases treated with anti-TNF␣ or anti-leukocyte adhesion therapy report marked improvements in quality of life Revicki et al., 2007; Rudick et al., 2007; Loftus et al., 2008; Putzki et al., 2009; Strand and Khanna, 2010; Dougados et al., 2012) .
Systemic inflammatory diseases are commonly associated with activation of circulating leukocytes and elevated circulating cytokine levels (e.g., TNF␣; Neuman et al., 2002) which in turn can mediate activation of vascular endothelium. In addition, stimulation of neural pathways of communication involving vagal afferents can lead to microglial activation, which in turn can impact CEC phenotype. Activation of CECs is an important step in relaying signals from the periphery to the brain (Gosselin and Rivest, 2008) . We now show that in mice with hepatic inflammation, at a time when changes in neural excitability and development of sickness behaviors are evident, circulating monocytes interact with CECs. Despite the presence of monocyte rolling and adhesion along CECs, we could not detect any increase in cerebral monocyte infiltration in inflamed mice at this time. This is an important observation because monocytes that infiltrate the brain could produce mediators, such as TNF␣, that can promote microglial activation and changes in neurotransmission (Kuno et al., 2005) . Although, we previously documented cerebral monocyte recruitment after more prolonged liver inflammation (day 10 post-BDL; D'Mello et al., 2009), our current studies demonstrate that monocyte-CEC adhesive interactions play a key role in mediating sickness behaviors, without a need for monocyte infiltration into the brain. Furthermore, our observations in day 5 BDL mice suggest an inability of monocytes to transmigrate across CECs despite overt ongoing monocyte-CEC adhesive interactions. Similar observations of delayed cerebral monocyte infiltration have also been made by AudoyRémus et al. (2008) , who documented a rapid increase in the number of monocytes adherent to CECs (as observed immunohistochemically) in response to peripheral LPS administration. However, significantly increased numbers of monocytes were not evident in the cerebral perivascular space until 3 d post-LPS treatment.
Our current studies identify P-selectin and PSGL-1 as critical mediators of monocyte-CEC adhesive interactions in BDL mice. This observation was somewhat surprising as P-selectin also supports neutrophil rolling along vascular endothelium (Carvalho-Tavares et al., 2000; Månsson et al., 2000) . In addition, acute systemic injection of TNF␣ in mice has been shown to promote neutrophil predominant rolling/adhesion along CECs (Carvalho-Tavares et al., 2000) . These findings suggest that more prolonged exposure, to what are likely a wider range of circulating inflammatory stimuli, may drive recruitment of leukocytes along the cerebral vasculature from an earlier neutrophil to a later monocyte predominant process. Interestingly, this type of shift has been suggested to occur in models of atherosclerosis (Hristov and Weber, 2011) . Another possibility includes the generation by CECs of a mediator that inhibits neutrophil adherence. Consistent with this hypothesis, iNOS expression was increased in CECs in BDL mice, and nitric oxide has been reported to prevent neutrophil adhesive interactions with vascular endothelium (Hickey et al., 1997) . These suggestions warrant further investigation.
For the first time, we demonstrate that microglial activation is intimately linked to TNF␣-driven monocyte adhesive interactions with CECs during peripheral organ inflammation. Specifically, inhibition of peripheral TNF␣ signaling prevented monocyte-CEC adhesive interactions, activation of microglia and sickness behavior development; an effect mirrored by directly preventing monocyte-CEC adhesive interactions by blocking P-selectin. Anti-Pselectin therapy has not previously been associated with improvement in inflammation associated altered behavior and symptoms. Our observations parallel findings in the clinical setting where patients with multiple sclerosis or Crohn's disease, treated systemically with anti-␣ 4 -integrin therapy, report marked improvements in symptoms and quality of life Rudick et al., 2007; Targan et al., 2007; Putzki et al., 2009) . Furthermore, ours are the first data demonstrating that peripheral organ inflammation can drive endothelial-immune cell interactions at sites remote from the inflamed tissue, and that these adhesive interactions can subsequently drive activation of cells deeper within a tissue, which are removed from the general circulation (microglia in this case). These findings may also have implications for understanding how inflammation at one site can lead to diseases at sites remote from the inflammation (e.g., gingivitis associated with coronary artery disease and atherosclerosis (Cairo et al., 2009) , which are also monocyte driven disorders. Furthermore, we present evidence that iNOS induction in CECs links peripheral TNF␣ signaling to microglial activation. Although, increased iNOS expression in the brain has been demonstrated in models of systemic LPS-induced inflammation (Wong et al., 1996) , to our knowledge our findings are the first to link peripheral organ inflammation, iNOS, and microglial activation.
The link between peripheral cytokines, microglia, and neural excitability is poorly understood, but is of obvious potential clinical relevance. Previously showed that colitic mice have enhanced seizure susceptibility which was associated with microglial activation and increased hippocampal TNF␣ levels. Moreover, blocking central TNF␣ resulted in normalization of seizure thresholds in colitic mice. We demonstrate that hepatic inflammation is linked to depressed central neural excitability, a process that could be reversed by blocking peripheral TNF␣ signaling and/or monocyte-CEC adhesive interactions. These findings would suggest that central and peripheral TNF␣ may be acting via different mechanisms in altering central neurotransmission. Furthermore, these exciting observations are consistent with clinical data from patients with a number of peripheral inflammatory diseases who demonstrate marked improvements in sickness behaviors upon receiving systemic anti-TNF␣ therapy (Revicki et al., 2007; Loftus et al., 2008; Strand and Khanna, 2010) .
Our novel observations highlight a new signaling pathway between an inflamed organ and the brain, which plays a key role in microglial activation, alterations in neural excitability and sickness behavior development. These findings have significant implications for our understanding of mechanisms leading to changes within the brain which are commonly associated with peripheral inflammatory diseases, and which often lead to marked reductions in patient quality of life. Moreover, this pathway offers a number of potential targets for therapeutic intervention.
